Quantitative variations in beta-lactam antibiotic released endotoxin from Pseudomonas aeruginosa: in-vivo relevance.
Jackson
J J
JJ
Antibiotic Discovery and Development, Merck Research Laboratories, Rahway, NJ 07065, USA.
Kropp
H
H
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002442:Ceftazidime / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D004731:Endotoxins / Q000096:biosynthesis* / Q000633:toxicity; D006801:Humans; D015378:Imipenem / Q000494:pharmacology; D007928:Lethal Dose 50; D008070:Lipopolysaccharides / Q000096:biosynthesis / Q000633:toxicity; D051379:Mice; D008855:Microscopy, Electron, Scanning; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000209:etiology; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000472:pathogenicity* / Q000648:ultrastructure
D000900:Anti-Bacterial Agents; D004731:Endotoxins; D008070:Lipopolysaccharides; D015378:Imipenem; D002442:Ceftazidime